The Assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1). Journal of Pharmaceutical Negative Results 2022, 13 (1), 39-43.